Opinion · 30 Dec 2024
Research articlePublished 15 Sep 2012
Isolation and Characterization of Mesenchymal Stem Cells from Human Fetal Liver; Potential Candidates for Replacement Therapy in Liver Disease
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Liver cell transplantation (LCT) is emerging as an alternative to organ transplantation in the treatment of liver disease since tissue unavailability and immunological incompatibilities are still major obstacles. Primary human hepatocytes are the first choice for LCT. However the unavailability of liver donors, the need for high numbers of hepatocytes for transplantation, immunological rejection, and low activity and inability to expand hepatocytes in vitro are limiting factors.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Liver: Disease & Transplantation.
Opinion · 30 Dec 2024
Epidemiology of Alcohol-Associated Liver Disease: Trends and Implications for Public Health
Opinion · 30 Dec 2024
Advances in Regenerative Medicine and Stem Cell Therapies for Liver Cirrhosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Liver: Disease & Transplantation
- SubjectGastroenterology & Hepatology
- SubjectSurgery
- BylineArticles whose byline prints “Mohammed Saliem”
- BylineArticles whose byline prints “Bo-G?ran Ericzon”
- BylineArticles whose byline prints “Ewa Ellis”
- BylineArticles whose byline prints “Outi Hovatta”
- BylineArticles whose byline prints “Cecilia G?therstr?m”
